MG
Therapeutic Areas
Oncovita Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MVdeltaC | Pleural Mesothelioma | Pre-clinical |
| Measovir®-based candidate | Bladder Cancer | Pre-clinical |
| Measovir®-based Prophylactic Vaccine (with Unither) | Undisclosed | Research/Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| MVdeltaC | Pleural Mesothelioma | Pre-clinical |
| Measovir®-based candidate | Bladder Cancer | Pre-clinical |
| Measovir®-based Prophylactic Vaccine (with Unither) | Undisclosed | Research/Pre-clinical |